| Execution period | Effective from May 11, 2026 |
|---|
BSE filing, NSE: BIJHANS. Summary written from the filing by ALFA Finder's alert engine.
Bijoy Hans Ltd: key numbers
- Share price
- ₹118.45
- Market cap
- ₹568.8 Cr
- Revenue (annual)
- ₹9.11 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 369.1×Sector 45.0×
- Promoter holding
- 28.33%-2.29% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bijoy Hans Ltd
All →Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Arvaya Healthcare Acquisition
Arvaya Healthcare completed the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited on 1 November 2026. The target is now a wholly-owned subsidiary, with no consideration amount disclosed.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare schedules a 4 November 2026 board meeting on rights issue, draft letter of offer and related party transactions. Agenda items remain proposed only.
Arvaya Healthcare Preferential Issue
Director Bidari Kotresh Anilkumar acquired 591,129 Arvaya Healthcare shares through a preferential offer. Holding rises to 4.45% from 3.58%.
Arvaya Healthcare Preferential Issue
Arvaya Healthcare allotted 38,71,854 equity shares at Rs.40 each to 47 SIGPL shareholders in a share swap. The allotment is valued at Rs.15.49 Crore.
- Value
- ₹15.49 Cr
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr
Baba Arts Capital Structure Change
Skybridge Interactive LLP, a non-promoter acquirer, disclosed under Reg 29(2) that it acquired 65,00,000 shares of Baba Arts, raising its stake from 62.28% to 74.67%. The acquisition was off-market under a share purchase agreement dated 25 February 2026.